Author of the publication

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

A. Antoniou, J. Beesley, L. McGuffog, O. Sinilnikova, S. Healey, S. Neuhausen, Y. Ding, T. Rebbeck, J. Weitzel, H. Lynch, C. Isaacs, P. Ganz, G. Tomlinson, O. Olopade, F. Couch, X. Wang, N. Lindor, V. Pankratz, P. Radice, S. Manoukian, B. Peissel, D. Zaffaroni, M. Barile, A. Viel, A. Allavena, V. Dall'Olio, P. Peterlongo, C. Szabo, M. Zikan, K. Claes, B. Poppe, L. Foretova, P. Mai, M. Greene, G. Rennert, F. Lejbkowicz, G. Glendon, H. Ozcelik, I. Andrulis, M. Thomassen, A. Gerdes, L. Sunde, D. Cruger, U. Birk Jensen, M. Caligo, E. Friedman, B. Kaufman, Y. Laitman, R. Milgrom, M. Dubrovsky, S. Cohen, A. Borg, H. Jernström, A. Lindblom, J. Rantala, M. Stenmark-Askmalm, B. Melin, K. Nathanson, S. Domchek, A. Jakubowska, J. Lubinski, T. Huzarski, A. Osorio, A. Lasa, M. Durán, M. Tejada, J. Godino, J. Benitez, U. Hamann, M. Kriege, N. Hoogerbrugge, van der Luijt, Rob B, van Asperen, Christi J, P. Devilee, E. Meijers-Heijboer, M. Blok, C. Aalfs, F. Hogervorst, M. Rookus, M. Cook, C. Oliver, D. Frost, D. Conroy, D. Evans, F. Lalloo, G. Pichert, R. Davidson, T. Cole, J. Cook, J. Paterson, S. Hodgson, P. Morrison, M. Porteous, L. Walker, M. Kennedy, H. Dorkins, S. Peock, A. Godwin, D. Stoppa-Lyonnet, A. Pauw, S. Mazoyer, V. Bonadona, C. Lasset, H. Dreyfus, D. Leroux, A. Hardouin, P. Berthet, L. Faivre, C. Loustalot, T. Noguchi, H. Sobol, E. Rouleau, C. Nogues, M. Frénay, L. Vénat-Bouvet, J. Hopper, M. Daly, M. Terry, E. John, S. Buys, Y. Yassin, A. Miron, D. Goldgar, C. Singer, A. Dressler, D. Gschwantler-Kaulich, G. Pfeiler, Hansen, Thomas V O, L. Jønson, B. Agnarsson, T. Kirchhoff, K. Offit, V. Devlin, A. Dutra-Clarke, M. Piedmonte, G. Rodriguez, K. Wakeley, J. Boggess, J. Basil, P. Schwartz, S. Blank, A. Toland, M. Montagna, C. Casella, E. Imyanitov, L. Tihomirova, I. Blanco, C. Lazaro, S. Ramus, L. Sucheston, B. Karlan, J. Gross, R. Schmutzler, B. Wappenschmidt, C. Engel, A. Meindl, M. Lochmann, N. Arnold, S. Heidemann, R. Varon-Mateeva, D. Niederacher, C. Sutter, H. Deissler, D. Gadzicki, S. Preisler-Adams, K. Kast, I. Schönbuchner, T. Caldes, de la Hoya, Miguel, K. Aittomäki, H. Nevanlinna, J. Simard, A. Spurdle, H. Holland, X. Chen, R. Platte, G. Chenevix-Trench, and D. Easton. Cancer research, 70 (23): 9742–9754 (2010)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

Wassil Zikandeloff

Michal Olszewski

Michal Pejko

Michal Novotny

Michal Fic

Other publications of authors with the same name

RAD51 135G--C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studiesA. Antoniou, O. Sinilnikova, J. Simard, M. Léoné, M. Dumont, S. Neuhausen, J. Struewing, D. Stoppa-Lyonnet, L. Barjhoux, D. Hughes and 69 other author(s). American journal of human genetics, 81 (6): 1186–1200 (2007)Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk predictionA. Antoniou, J. Beesley, L. McGuffog, O. Sinilnikova, S. Healey, S. Neuhausen, Y. Ding, T. Rebbeck, J. Weitzel, H. Lynch and 168 other author(s). Cancer research, 70 (23): 9742–9754 (2010)Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersX. Wang, V. Pankratz, Z. Fredericksen, R. Tarrell, M. Karaus, L. McGuffog, Pharaoh, Paul D P, Ponder, Bruce A J, A. Dunning, S. Peock and 34 other author(s). Human molecular genetics, 19 (14): 2886–2897 (2010)AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 studyF. Couch, O. Sinilnikova, R. Vierkant, V. Pankratz, Z. Fredericksen, D. Stoppa-Lyonnet, I. Coupier, D. Hughes, A. Hardouin, P. Berthet and 61 other author(s). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 16 (7): 1416–1421 (2007)Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriersA. Antoniou, O. Sinilnikova, L. McGuffog, S. Healey, H. Nevanlinna, T. Heikkinen, J. Simard, A. Spurdle, J. Beesley, X. Chen and 127 other author(s). Human molecular genetics, 18 (22): 4442–4456 (2009)

BibSonomy

Disambiguation of "Zikan, Michal"

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

Please choose a person to relate this publication to

Wassil Zikandeloff

Michal Olszewski

Michal Pejko

Michal Novotny

Michal Fic

Other publications of authors with the same name

Disambiguation

BibSonomy

Disambiguation of "Zikan, Michal"

copydeleteadd this publication to your clipboardcommunity posthistory of this postURLDOIBibTeXEndNoteAPAChicagoDIN 1505HarvardMSOffice XML Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction

Please choose a person to relate this publication to

Wassil Zikandeloff

Michal Olszewski

Michal Pejko

Michal Novotny

Michal Fic

Other publications of authors with the same name

Disambiguation

copy delete add this publication to your clipboard
community post
history of this post
URL
DOI
BibTeX
EndNote
APA
Chicago
DIN 1505
Harvard
MSOffice XML

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction